Residual Graft Pathology During CABG as a Minimally Invasive Diagnostic Pathway for Transthyretin Amyloidosis.

Amvuttra (vutrisiran) - Alnylam

http://www.ncbi.nlm.nih.gov/pubmed/42138667

Asuka Kuwahara; Atsushi Okada; Chisato Izumi; Emi Tateishi; Kenta Yamaguchi; Manabu Matsumoto; Naonori Kawamoto; Rieko Kutsuzawa; Satsuki Fukushima; Takeshi Kitai

May 18, 2026